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ABSTRACT 
Background: Gastro-oesophageal reflux (GOR) is common in children with cystic 
fibrosis (CF) and is thought to be associated with pulmonary aspiration of gastric 
contents. Recently the measurement of pepsin in bronchoalveolar lavage (BAL) has been 
suggested to be a reliable indicator of aspiration. We assessed the prevalence of 
pulmonary aspiration in a group of children with CF and investigated its association with 
lung inflammation. 
 
Methods: This was a cross-sectional case-control study. BAL was collected from 
individuals with CF (n=31) and healthy controls (n=7). Interleukin-8 (IL-8), pepsin, 
neutrophil numbers and neutrophil elastase (NE) activity levels were measured in all 
samples. Clinical, microbiological and lung function data were collected from medical 
notes.  
 
Results: BAL pepsin concentration was higher in the CF group (mean 24.4 [SD 27.4] 
ng/ml) compared to controls (4.3 [4] ng/ml, p=0.03).  Those with CF who had elevated 
pepsin concentrations had higher levels of BAL IL-8 (3.7 [2.7] ng/ml) compared to those 
with a concentration comparable to controls (1.4 [0.9] ng/ml, p=0.004). Within the CF 
group, we observed a moderate positive correlation between pepsin concentration and IL-
8 in BAL (r=0.48, p=0.04).  There was no association between BAL pepsin 
concentrations and age, sex, BMI z score, FEV1 or P. aeruginosa colonisation status. 
 
Conclusions: Many children with CF have elevated BAL pepsin levels compared to 
normal controls. Elevated pepsin levels were associated with higher IL-8 concentrations 
in BAL. These data suggest that aspiration of gastric contents occurs in a subset of 
patients with CF and is associated with more pronounced lung inflammation. 
 
  
 BACKGROUND 
 
The symptoms of gastro-oeophageal reflux (GOR) are very common in children with 
cystic fibrosis 1. Studies using oesophageal manometry and pH probes have demonstrated 
high levels of GOR in both children and adults with cystic fibrosis. Scott et al found 
GOR in 20% of those less than 5 years of age while Ledson et al, showed a prevalence of 
80% in adult patients, some of whom showed tracheal acidification in addition, 
suggesting micro-aspiration 1-3. According to Blondeau et al, GOR is common in adults 
with CF, and associated with increased cough and poorer lung function4. Several patients 
in that study had bile acids in their BAL, suggesting a link with aspiration. A study by 
Button et al found that GOR was present in 90% of severely-affected adult patients with 
CF pre-transplant and 84% post-transplant5. 
 
Diagnosis and treatment of GOR is a common component of care at most CF centres. 
Many patients will report symptom improvement with gastric acid suppressive therapy. 
However, treatment with acid blockade will not prevent non-acid reflux or its aspiration6. 
The detection and treatment of pulmonary aspiration is fraught with difficulty. The 
diagnosis is often made with a combination of clinical, laboratory and radiological tests. 
However, the overall sensitivity and specificity of these tests alone or in combination 
remains poor. An ideal test for aspiration would involve the detection of a marker within 
the lungs that clearly should not be present within the tracheobronchial tree under normal 
conditions. The marker ought to be easily recovered and reliably detectable for a period 
of time after acute aspiration.  Recently, several investigators have focused on pepsin, a 
digestive protease that degrades food proteins into peptides. It is expressed as a pro-form 
zymogen, pepsinogen, which is released by chief cells in the stomach and subsequently 
activated by hydrochloric acid (HCl) cleaving it to the active form, pepsin. A link 
between pulmonary aspiration and the detection of pepsin in tracheal aspirates or BAL 
has been demonstrated in human and animal studies7-16. Farrell et al,  recently employed 
the pepsin ELISA used in this study to look specifically at aspiration of gastric contents 
in children without CF10. 
 
Given the increased prevalence of gastro-esophageal reflux in children with CF1-4, and 
the link between aspiration of gastric contents and lung inflammation17, we sough to 
determine whether pulmonary aspiration was occurring in children with CF,  and if so, 
whether this was associated with more marked pulmonary inflammation.  
METHODS 
Patient selection 
We studied a consecutive group of children with CF referred for bronchoscopy during the 
period July 2005 – July 2007 who satisfied the selection criteria and provided written 
informed consent. There was a range of different indications for these procedures; For 
routine microbiological surveillance in non sputum producers, to	  confirm	  or	  follow	  up	  a	  growth	  of	  P.	  aeruginosa	  in	  a	  throat	  swab,	  to	  investigate	  ongoing	  respiratory	  symptoms	  out	  of	  context	  with	  culture	  results,	  and	  in	  some	  cases,	  opportunistically	  at	  the	  time	  of	  other	  elective	  procedures	  in	  these	  patients.	  Inclusion criteria were as 
follows: Age 0-17 years, an abnormal sweat test and the presence of at least one CF 
mutation. Exclusion criteria were as follows: Presence of an acute CF exacerbation, a 
diagnosis of allergic bronchopulmonary aspergillosis, treatment with systemic steroids 
and a clinical diagnosis of asthma. Non-CF healthy control samples were obtained from 
children without lung disease undergoing elective non-pulmonary surgical procedures. 
Inclusion criteria were as follows: age 0-17 years. Exclusion criteria were as follows: 
Any history of recurrent respiratory symptoms, respiratory symptoms on the day of 
surgery or a diagnosis of asthma. Full informed parental consent was obtained for all 
procedures and ethical approval was obtained from the institutional review board of the 
Adelaide and Meath Hospital incorporating the National Children’s Hospital, Dublin. 
 
Bronchoalveolar lavage fluid 
Bronchoscopy was performed via a laryngeal mask airway to avoid contamination from 
the upper airway and aspiration of gastric contents during the procedure. Bronchoalveolar 
lavage was performed in the lingula and right middle lobe by instilling 1 ml/kg of sterile 
normal saline per lobe. Return was typically in the region of 40%. Specimens from right 
and left lungs were pooled. BAL fluid was centrifuged at 2000 x g for 10 min and the 
supernatant aliquoted and stored at -80°C.  
 
Pepsin ELISA 
Pepsin concentrations were measured in clinical samples by an ‘in-house’ ELISA assay 
with anti-porcine pepsin antibodies developed at the Queens University Belfast, as 
previously described10 (See appendix 1). 
 
IL-8 ELISA 
IL-8 was measured by ELISA using 1:125 mouse anti-IL-8 as primary antibody and 
1:2500 biotinylated goat anti-IL-8 as detection antibody (all R&D systems, Abingdon, 
Oxon, UK). 
 
Study design and sample size estimation  
This was a cross-sectional case-control study. All relevant demographic, clinical, and 
laboratory data were collected from the patients medical notes and recorded in a 
dedicated case record form. There were limited data to inform sample size calcultion, 
however estimates were calculated using the Satterthwaite t-test of equal means (unequal 
variances, unequal groups). Presuming a minimum average pepsin concentration of 24 
ng/ml in cases (based on pepsin values in children with aspiration)10 and a maximum  
average pepsin concentration of <5 ng/ml in control subjects, with a ratio of cases to 
controls of 5:1, and at two-tailed p<0.05 (power > 85%), a minimum of 27 cases and 5 
controls  were required.   
  
Statistical analyses  
Descriptive statistics and percentile methods were used. The normality of the distribution 
of continuous variables was assessed by the Kolmogorov-Smirnov test. The groups and 
sub-groups were compared by two-tailed independent sample Student's t-test when 
normally distributed, or alternatively, by the non-paramtric Mann-Whitney test, as 
appropriate. The associations between different variables among children with CF were 
evaluated by univariate analyses. Pearson’s correlation coefficient was used for 
establishing correlations between normally distributed continuous variables, or, 
alternatively, the Spearman rho coefficient was used. Continuous data are expressed as 
mean and [standard deviation] or SD, unless otherwise specified. The statistical 
significance of all tests was assumed at two-tailed p<0.05. All analyses were performed 
with GraphPad Prism software.
 RESULTS 
Study patients 
Overall, 31 cases with CF and 15 controls were identified as eligible participants (see 
Table 1). After identification, only 8 controls did not provide written informed consent 
and did not participate and complete the study. Finally, out of all 46 identified subjects, a 
total of 38 subjects were recruited and analysed (n=31 cases, average age 10.4 years, 
range 0.4-17.7 years; n=7 controls, average age 8.3 years, range 3.7-15.1 years).  
  
 
Clinical characteristics 
There was no significant difference in age or gender distribution, P. aeruginosa 
colonisation status or previous investigations for GOR between the two groups of 
individuals with CF (CF with high versus CF with low BAL pepsin concentration, Figure 
2). 
 
BAL pepsin is elevated in individuals with CF 
Mean pepsin levels in the CF group (24.4 [27.4] ng/ml) were higher than those in the 
control group (4.3 [4.0] ng/ml, p=0.03, Figure 1). It should be noted that some pepsin 
was detected in most samples, even controls. A large proportion (12 out of 31) of the CF 
group had pepsin levels within the same range as the control group. As a low 
concentration of pepsin was detectable in BAL from controls, the pepsin concentration in 
those with CF were considered ‘high’ if it was ≥95th percentile for controls (10.4ng/ml), 
and ‘low’ if they were below this value. 	  
BAL pepsin correlates with IL-8 in individuals with CF 
We sought to investigate whether this increase in pepsin values was associated with 
increased evidence of inflammation. BAL IL-8 levels were significantly higher in those 
with high pepsin levels (3.7 [2.7] ng/ml) compared to those with low pepsin (1.4 [0.9] 
ng/ml, p=0.004 , Figure 2). Furthermore, there was a positive correlation between BAL 
pepsin and BAL IL-8 in the group with CF (r=0.48, n=31, Figure 3). Increased BAL 
neutrophil counts were observed in the CF group with high BAL pepsin concentrations 
compared to those with low BAL pepsin concentrations (5.5 [6.9] v 2.6 [3.8] x 106 
cells/ml) although the difference was not statistically significant (pt-test=0.15). 
 DISCUSSION 
In this study of children with CF undergoing bronchoscopy as part of their clinical care, 
we found that in more than half, BAL pepsin concentrations were elevated in keeping 
with pulmonary aspiration. Moreover, those with higher BAL pepsin concentrations also 
had higher IL8 concentrations suggesting that ongoing pulmonary aspiration is 
contributing to airways inflammation 
 
The diagnosis of pulmonary aspiration remains a challenge. No single test to date has 
been demonstrated to be 100% sensitive or specific, and the diagnosis is often based on 
clinical suspicion with some supporting evidence from radiological, laboratory and 
physiological tests. Up to now, the most widely used method for detection of pulmonary 
aspiration has been microscopic analysis of secretions for the presence of lipid-laden 
macrophages. An index comparing the proportion of lipid laden to normal macrophages 
must be calculated and used for comparison – the lipid laden macrophage index (LLMI). 
This test is labour intensive, operator dependent and has poor specificity and variable 
sensitivity 18;19. No clear reference standards exist for this method. The technique has 
been evaluated in children with CF. Kazachkov et al found elevated LLMI in children 
both with CF, and with other chronic pulmonary conditions, but no normal controls were 
assessed.  The LLMI was higher in the CF group, but this did not correlate with 
inflammatory markers in BAL or symptoms suggestive of GOR in either group 20. 
 
In situations where aspiration of gastric refluxate into the lungs is strongly suspected, the 
definitive treatment usually involves surgical fundoplication. However, surgical 
procedures in CF, especially those which may alter physiological function, are not 
undertaken lightly and robust evidence for their need should be obtained. The 
measurement of pepsin levels in BAL has the potential to provide such confirmatory 
documentation.  Pepsin assays have the potential to significantly improve the sensitivity 
and specificity of the current diagnostic approach to aspiration in the clinical setting. The 
pepsin assay used in this study was specifically developed and validated for detection of 
pulmonary aspiration in children10.  
 
The fact that pepsin is produced in the GI tract and not the lung fulfils one of the most 
important requirements of a reliable marker of aspiration. However a study in healthy 
young adults has shown that a significant portion of patients aspirate nasopharyngeal 
secretions during sleep21. In patients with GOR, where upper oesophageal sphincter tone 
drops during deep sleep, the potential exists for some micro-aspiration of gastric 
contents22. So the presence per se of pepsin, at any level, in the BAL may not necessarily 
always be an abnormal finding.  In this context, the detection of low levels of pepsin in 
the BAL of some of our control patients is perhaps not surprising. Several of the 
individuals with CF have similarly low levels of pepsin, however many more had levels 
that were significantly elevated above control values, perhaps indicating more significant 
degrees of aspiration. A clear segregation between low and high pepsin can be observed 
using the 95th percentile cut off (Figure 1). There are no published data for the 
concentration of pepsin in the BAL that may be seen in the absence of respiratory 
symptoms or pulmonary inflammation, so deciding which levels are potentially 
physiological and which are clearly pathological presents a challenge. Individuals in the 
control group were completely asymptomatic from a respiratory perspective at the time of 
bronchoscopy, and had normal differential cell counts and negligible levels of 
inflammatory cytokines (data not shown) in BAL. Therefore we feel confident that the 
pepsin levels measured in this group are unlikely to be clinically significant and represent 
a true normal range. The presence of low levels of pepsin in otherwise healthy children is 
surprising, but may reflect microaspiration during sleep as has been shown in adults. 
Little is known about how long pepsin may be detectable in the lungs after aspiration of 
gastric contents. 
 
The finding of elevated levels of IL-8 among the group with the higher pepsin levels, and 
the correlation between levels of IL-8 and pepsin in BAL suggests that high pepsin levels 
are associated with more severe lower airway inflammation. Similar findings have been  
observed  in lung transplant recipients16;23. This is the first time that a link has been 
demonstrated between a biological marker of aspiration and inflammation in relatively 
stable individuals with CF (mean FEV1= 66%). This association is strengthened by the 
fact that both measurements are derived from the same sample from any given patient, 
minimising the effect of even small variations in BAL concentration between patients. 
Our finding of the link between pulmonary aspiration and inflammation in CF is 
potentially an extremely important discovery for individuals with CF. Indeed the 
relevance is amplified when one considers that many of the children in the study had no 
symptoms of GOR. Thus, it seems likely that silent aspiration of gastric contents may be 
a more common problem than most CF clinicians would anticipate.  
 
Contrary to what one might expect, we found no increase in pepsin levels in BAL with 
age, nor did we see an association between pepsin levels in BAL and lung function. This 
may be the result of our small numbers, and the cross sectional nature of this study. It is 
likely that the degree of aspiration in patients varies over time21, so a longitudinal study 
may be better equipped to address these associations.  
 
This study demonstrates for the first time that aspiration of gastric contents occurs in a 
subset of clinically stable patients with CF and is associated with more pronounced lung 
inflammation. Further longitudinal study is required to determine the long-term clinical 
significance of this observation. 
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Figures and Tables 
 
Table 1: Baseline characteristics and mean BAL pepsin values between the two 
groups. Differences	  in	  individual	  means	  were	  calculated	  by	  Student’s	  t	  test	  for	  continuous	  data,	  and	  chi	  squared	  for	  categorical	  data.	  
 
  Cases (n=31) Controls (n=7) p value 
    
Age (mean, [range]) 10.4 [0.4-17.7] 8.3 [3.7-15.1] 0.51 
Gender (M/F) 20/11 3/4 0.30 
Pepsin values (ng/ml) 24.4 +/- 27.4 4.3 +/- 4 0.03 
       
 
 
 
Table 2: Summary of clinical characteristics, test results and BAL inflammatory 
indices between the group of CF patients with high pepsin levels and those with low 
levels. Differences in individual means were calculated by Student’s t test or Mann 
Whitney test for continuous data, and chi-square test for categorical data. PPI: proton 
pump inhibitor. FEV1: Forced expiratory volume in one second. BMI: Body mass index. 
NS: Not significant. 
 
  High Pepsin (n=19) Low Pepsin (n=12) p value 
    
Age (mean) 10.73 10.07 0.79 
Gender (M/F) 13/6 7/5 0.53 
Neutrophils (x106/ml BAL) 5.52 2.61 0.15 
BMI z score -0.94 -0.7 0.66 
FEV1 (% predicted) 63 68.4 0.73 
BAL NE activity (nM) 56 37 0.29 
PPI use 6/19 (32%) 3/12 (25%) 0.69 
pH probe performed 5/19 (26%) 1/12 (8%) 0.21 
positive pH probe 5/5 (100%) 1/1 (100%) NS 
Chronic P. aeruginosa Colonisation 6/19 (32%) 3/12 (25%) 0.69 
 Figure 1: Pepsin levels in BAL from controls and patients with CF. The dotted line 
(10.4ng/ml) represents the 95th percentile value in the controls. Differences in individual 
means were assessed by Student’s t test. 
	  
 
Figure 2: BAL IL-8 levels in CF patients with high and low BAL pepsin values. 
Differences in means were analysed by Student’s t test. 
 Figure 3: Correlation between BAL pepsin level and BAL IL-8 among patients with 
CF. Correlation was determined by Pearson’s correlation coefficient.  
